ALEX HUA: Open Payments
NPI 1982488250 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,602 in 45 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $68 · 2025 $1,602
Food & beverage: $1,407Education: $195
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $620 |
| Incyte Corporation | 5 | $189 |
| GENZYME CORPORATION | 6 | $169 |
| Janssen Biotech, Inc. | 3 | $157 |
| SANOFI-AVENTIS U.S. LLC | 1 | $95 |
| Regeneron Healthcare Solutions, Inc. | 2 | $73 |
| Galderma Laboratories, L.P. | 3 | $68 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $61 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Arcutis Biotherapeutics, Inc. | 2 | $48 |
Products named: SKYRIZI, DUPIXENT, OPZELURA, TREMFYA, NEMLUVIO, Winlevi, COSENTYX, Zoryve.
Industry payments across CA — which companies pay providers there.
